Browsing tag:

Drug Development


Risk Management Practices

It may seem odd to be discussing sourcing challenges considering the overwhelming evidence we now have of what can happen to global (and even local) supply chains when disaster strikes, but while the coronavirus pandemic certainly has put the spotlight on the risks of global supply chains, it by no means created those risks. Indeed,[…]

Read More

API Sourcing Challenges

Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of sourcing active pharmaceutical ingredients (APIs) and intermediates has also become more challenging. In 2018, ISR Reports looked at how experience and capacity impact small molecule API outsourcing. Among the findings, about 25% of respondents indicated their company lacked the capacity[…]

Read More

BOCA RATON, Florida – Robert Hoppes, Director of Sales for R&D for LGM Pharma, a supplier of active pharmaceutical ingredients (APIs) in Boca Raton, Florida, recently attended the Drug Development Boot Camp offered by Speid & Associates, Inc. and Harvard University’s Office of Technology Development. This intensive two-day course for Biotech and Pharma company executives[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service